Are you Dr. Heald?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-744-3000
Summary
- Dr. Alison Heald, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and North Carolina. She is affiliated with UW Medicine/Harborview Medical Center.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 1995 - 1996
Yale-New Haven Medical CenterResidency, Internal Medicine, 1986 - 1989
Perelman School of Medicine at the University of PennsylvaniaClass of 1986
Certifications & Licensure
WA State Medical License 2000 - 2026
NC State Medical License 1992 - 2001- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
- Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects Start of enrollment: 2005 Aug 01
- Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94 Start of enrollment: 2004 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsSafety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults.Sean M Amberg, Benjamin Snyder, Portia A Vliet-Gregg, Eric J Tarcha, Jeff Posakony
Antimicrobial Agents and Chemotherapy. 2022-11-15 - 16 citationsSafety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1/M2 translation.John H. Beigel, Jocelyn Voell, Paula Muñoz, Parag Kumar, Kristina M Brooks
British Journal of Clinical Pharmacology. 2018-01-01 - 22 citationsDelayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques.Travis K. Warren, Chris A. Whitehouse, Jay Wells, Lisa S. Welch, Jay S. Charleston
Plos Neglected Tropical Diseases. 2016-02-22
Press Mentions
Drug Might Fight Ebola-like Marburg VirusJuly 23rd, 2015
